
Custom assay development refers to the process of designing and optimizing a specific assay or test for the detection, quantification, or characterization of a particular analyte or target molecule. This can include the development of new assays from scratch or the modification and optimization of existing assays to meet specific research or diagnostic needs.
Custom assay development typically involves several steps, including:
1. Target identification: Identifying the specific analyte or target molecule that needs to be detected or measured.
2. Assay design: Designing the assay format, including the choice of detection method (e.g., fluorescence, luminescence, colorimetry), the selection of appropriate reagents and controls, and the determination of assay conditions (e.g., temperature, pH).
3. Reagent selection and optimization: Selecting or developing the necessary reagents, such as antibodies, probes, enzymes, or substrates, and optimizing their concentrations and conditions to achieve optimal assay performance.
4. Validation and optimization: Testing and optimizing the assay to ensure its sensitivity, specificity, accuracy, precision, and robustness. This may involve adjusting assay conditions, optimizing incubation times, or testing different sample types.
5. Quality control: Implementing quality control measures to ensure the reliability and reproducibility of the assay, such as establishing appropriate controls, monitoring assay performance over time, and implementing quality assurance protocols.
Custom assay development is commonly used in various fields, including biomedical research, drug discovery, clinical diagnostics, environmental monitoring, and food safety testing. It allows researchers and scientists to tailor assays to their specific needs, enabling the detection and measurement of analytes that may not be easily detected by commercially available assays.
Market Analysis and Insights: Global Custom Assay Development Market
The global Custom Assay Development market is projected to grow from US$ 28600 million in 2024 to US$ 37460 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period.
The US & Canada market for Custom Assay Development is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Custom Assay Development is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Custom Assay Development is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Custom Assay Development include 2BScientific, PerkinElmer, Eurofins Discovery, Thermo Fisher Scientific, Creative Biolabs, PlexBio, Gyros Protein Technologies, Mission Bio and Sygnature Discovery, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Custom Assay Development is widely used in various fields, such as Medicine, Biology, Environment and Academic, etc. Medicine provides greatest supports to the Custom Assay Development industry development. In 2023, global % revenue of Custom Assay Development went into Medicine filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Custom Assay Development market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Custom Assay Development, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Custom Assay Development, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Custom Assay Development revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Custom Assay Development market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Custom Assay Development revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
2BScientific
PerkinElmer
Eurofins Discovery
Thermo Fisher Scientific
Creative Biolabs
PlexBio
Gyros Protein Technologies
Mission Bio
Sygnature Discovery
AssayGate
Charles River Laboratories
Promega Corporation
ProteoGenix
R&D Systems
Luminex
Eremid Genomic Services
INDIGO Biosciences
Cellomatics Biosciences
Camtech
SynVivo
Segment by Type
Assay Development
Assay Optimization
Assay Conversion
New Analyte Development
Custom Coupling
Custom Conjugation
Sample Testing
Other
Segment by Application
Medicine
Biology
Environment
Academic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Custom Assay Development in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Custom Assay Development companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Assay Development revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Custom Assay Development Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Assay Development
1.2.3 Assay Optimization
1.2.4 Assay Conversion
1.2.5 New Analyte Development
1.2.6 Custom Coupling
1.2.7 Custom Conjugation
1.2.8 Sample Testing
1.2.9 Other
1.3 Market by Application
1.3.1 Global Custom Assay Development Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medicine
1.3.3 Biology
1.3.4 Environment
1.3.5 Academic
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Custom Assay Development Market Perspective (2019-2030)
2.2 Global Custom Assay Development Growth Trends by Region
2.2.1 Custom Assay Development Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Custom Assay Development Historic Market Size by Region (2019-2024)
2.2.3 Custom Assay Development Forecasted Market Size by Region (2025-2030)
2.3 Custom Assay Development Market Dynamics
2.3.1 Custom Assay Development Industry Trends
2.3.2 Custom Assay Development Market Drivers
2.3.3 Custom Assay Development Market Challenges
2.3.4 Custom Assay Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Custom Assay Development by Players
3.1.1 Global Custom Assay Development Revenue by Players (2019-2024)
3.1.2 Global Custom Assay Development Revenue Market Share by Players (2019-2024)
3.2 Global Custom Assay Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Custom Assay Development, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Custom Assay Development Market Concentration Ratio
3.4.1 Global Custom Assay Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Custom Assay Development Revenue in 2023
3.5 Global Key Players of Custom Assay Development Head office and Area Served
3.6 Global Key Players of Custom Assay Development, Product and Application
3.7 Global Key Players of Custom Assay Development, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Custom Assay Development Breakdown Data by Type
4.1 Global Custom Assay Development Historic Market Size by Type (2019-2024)
4.2 Global Custom Assay Development Forecasted Market Size by Type (2025-2030)
5 Custom Assay Development Breakdown Data by Application
5.1 Global Custom Assay Development Historic Market Size by Application (2019-2024)
5.2 Global Custom Assay Development Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Custom Assay Development Market Size (2019-2030)
6.2 North America Custom Assay Development Market Size by Type
6.2.1 North America Custom Assay Development Market Size by Type (2019-2024)
6.2.2 North America Custom Assay Development Market Size by Type (2025-2030)
6.2.3 North America Custom Assay Development Market Share by Type (2019-2030)
6.3 North America Custom Assay Development Market Size by Application
6.3.1 North America Custom Assay Development Market Size by Application (2019-2024)
6.3.2 North America Custom Assay Development Market Size by Application (2025-2030)
6.3.3 North America Custom Assay Development Market Share by Application (2019-2030)
6.4 North America Custom Assay Development Market Size by Country
6.4.1 North America Custom Assay Development Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Custom Assay Development Market Size by Country (2019-2024)
6.4.3 North America Custom Assay Development Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Custom Assay Development Market Size (2019-2030)
7.2 Europe Custom Assay Development Market Size by Type
7.2.1 Europe Custom Assay Development Market Size by Type (2019-2024)
7.2.2 Europe Custom Assay Development Market Size by Type (2025-2030)
7.2.3 Europe Custom Assay Development Market Share by Type (2019-2030)
7.3 Europe Custom Assay Development Market Size by Application
7.3.1 Europe Custom Assay Development Market Size by Application (2019-2024)
7.3.2 Europe Custom Assay Development Market Size by Application (2025-2030)
7.3.3 Europe Custom Assay Development Market Share by Application (2019-2030)
7.4 Europe Custom Assay Development Market Size by Country
7.4.1 Europe Custom Assay Development Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Custom Assay Development Market Size by Country (2019-2024)
7.4.3 Europe Custom Assay Development Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Custom Assay Development Market Size (2019-2030)
8.2 China Custom Assay Development Market Size by Type
8.2.1 China Custom Assay Development Market Size by Type (2019-2024)
8.2.2 China Custom Assay Development Market Size by Type (2025-2030)
8.2.3 China Custom Assay Development Market Share by Type (2019-2030)
8.3 China Custom Assay Development Market Size by Application
8.3.1 China Custom Assay Development Market Size by Application (2019-2024)
8.3.2 China Custom Assay Development Market Size by Application (2025-2030)
8.3.3 China Custom Assay Development Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Custom Assay Development Market Size (2019-2030)
9.2 Asia Custom Assay Development Market Size by Type
9.2.1 Asia Custom Assay Development Market Size by Type (2019-2024)
9.2.2 Asia Custom Assay Development Market Size by Type (2025-2030)
9.2.3 Asia Custom Assay Development Market Share by Type (2019-2030)
9.3 Asia Custom Assay Development Market Size by Application
9.3.1 Asia Custom Assay Development Market Size by Application (2019-2024)
9.3.2 Asia Custom Assay Development Market Size by Application (2025-2030)
9.3.3 Asia Custom Assay Development Market Share by Application (2019-2030)
9.4 Asia Custom Assay Development Market Size by Region
9.4.1 Asia Custom Assay Development Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Custom Assay Development Market Size by Region (2019-2024)
9.4.3 Asia Custom Assay Development Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Custom Assay Development Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Custom Assay Development Market Size by Type
10.2.1 Middle East, Africa, and Latin America Custom Assay Development Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Custom Assay Development Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Custom Assay Development Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Custom Assay Development Market Size by Application
10.3.1 Middle East, Africa, and Latin America Custom Assay Development Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Custom Assay Development Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Custom Assay Development Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Custom Assay Development Market Size by Country
10.4.1 Middle East, Africa, and Latin America Custom Assay Development Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Custom Assay Development Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Custom Assay Development Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 2BScientific
11.1.1 2BScientific Company Details
11.1.2 2BScientific Business Overview
11.1.3 2BScientific Custom Assay Development Introduction
11.1.4 2BScientific Revenue in Custom Assay Development Business (2019-2024)
11.1.5 2BScientific Recent Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Custom Assay Development Introduction
11.2.4 PerkinElmer Revenue in Custom Assay Development Business (2019-2024)
11.2.5 PerkinElmer Recent Developments
11.3 Eurofins Discovery
11.3.1 Eurofins Discovery Company Details
11.3.2 Eurofins Discovery Business Overview
11.3.3 Eurofins Discovery Custom Assay Development Introduction
11.3.4 Eurofins Discovery Revenue in Custom Assay Development Business (2019-2024)
11.3.5 Eurofins Discovery Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Custom Assay Development Introduction
11.4.4 Thermo Fisher Scientific Revenue in Custom Assay Development Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Details
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs Custom Assay Development Introduction
11.5.4 Creative Biolabs Revenue in Custom Assay Development Business (2019-2024)
11.5.5 Creative Biolabs Recent Developments
11.6 PlexBio
11.6.1 PlexBio Company Details
11.6.2 PlexBio Business Overview
11.6.3 PlexBio Custom Assay Development Introduction
11.6.4 PlexBio Revenue in Custom Assay Development Business (2019-2024)
11.6.5 PlexBio Recent Developments
11.7 Gyros Protein Technologies
11.7.1 Gyros Protein Technologies Company Details
11.7.2 Gyros Protein Technologies Business Overview
11.7.3 Gyros Protein Technologies Custom Assay Development Introduction
11.7.4 Gyros Protein Technologies Revenue in Custom Assay Development Business (2019-2024)
11.7.5 Gyros Protein Technologies Recent Developments
11.8 Mission Bio
11.8.1 Mission Bio Company Details
11.8.2 Mission Bio Business Overview
11.8.3 Mission Bio Custom Assay Development Introduction
11.8.4 Mission Bio Revenue in Custom Assay Development Business (2019-2024)
11.8.5 Mission Bio Recent Developments
11.9 Sygnature Discovery
11.9.1 Sygnature Discovery Company Details
11.9.2 Sygnature Discovery Business Overview
11.9.3 Sygnature Discovery Custom Assay Development Introduction
11.9.4 Sygnature Discovery Revenue in Custom Assay Development Business (2019-2024)
11.9.5 Sygnature Discovery Recent Developments
11.10 AssayGate
11.10.1 AssayGate Company Details
11.10.2 AssayGate Business Overview
11.10.3 AssayGate Custom Assay Development Introduction
11.10.4 AssayGate Revenue in Custom Assay Development Business (2019-2024)
11.10.5 AssayGate Recent Developments
11.11 Charles River Laboratories
11.11.1 Charles River Laboratories Company Details
11.11.2 Charles River Laboratories Business Overview
11.11.3 Charles River Laboratories Custom Assay Development Introduction
11.11.4 Charles River Laboratories Revenue in Custom Assay Development Business (2019-2024)
11.11.5 Charles River Laboratories Recent Developments
11.12 Promega Corporation
11.12.1 Promega Corporation Company Details
11.12.2 Promega Corporation Business Overview
11.12.3 Promega Corporation Custom Assay Development Introduction
11.12.4 Promega Corporation Revenue in Custom Assay Development Business (2019-2024)
11.12.5 Promega Corporation Recent Developments
11.13 ProteoGenix
11.13.1 ProteoGenix Company Details
11.13.2 ProteoGenix Business Overview
11.13.3 ProteoGenix Custom Assay Development Introduction
11.13.4 ProteoGenix Revenue in Custom Assay Development Business (2019-2024)
11.13.5 ProteoGenix Recent Developments
11.14 R&D Systems
11.14.1 R&D Systems Company Details
11.14.2 R&D Systems Business Overview
11.14.3 R&D Systems Custom Assay Development Introduction
11.14.4 R&D Systems Revenue in Custom Assay Development Business (2019-2024)
11.14.5 R&D Systems Recent Developments
11.15 Luminex
11.15.1 Luminex Company Details
11.15.2 Luminex Business Overview
11.15.3 Luminex Custom Assay Development Introduction
11.15.4 Luminex Revenue in Custom Assay Development Business (2019-2024)
11.15.5 Luminex Recent Developments
11.16 Eremid Genomic Services
11.16.1 Eremid Genomic Services Company Details
11.16.2 Eremid Genomic Services Business Overview
11.16.3 Eremid Genomic Services Custom Assay Development Introduction
11.16.4 Eremid Genomic Services Revenue in Custom Assay Development Business (2019-2024)
11.16.5 Eremid Genomic Services Recent Developments
11.17 INDIGO Biosciences
11.17.1 INDIGO Biosciences Company Details
11.17.2 INDIGO Biosciences Business Overview
11.17.3 INDIGO Biosciences Custom Assay Development Introduction
11.17.4 INDIGO Biosciences Revenue in Custom Assay Development Business (2019-2024)
11.17.5 INDIGO Biosciences Recent Developments
11.18 Cellomatics Biosciences
11.18.1 Cellomatics Biosciences Company Details
11.18.2 Cellomatics Biosciences Business Overview
11.18.3 Cellomatics Biosciences Custom Assay Development Introduction
11.18.4 Cellomatics Biosciences Revenue in Custom Assay Development Business (2019-2024)
11.18.5 Cellomatics Biosciences Recent Developments
11.19 Camtech
11.19.1 Camtech Company Details
11.19.2 Camtech Business Overview
11.19.3 Camtech Custom Assay Development Introduction
11.19.4 Camtech Revenue in Custom Assay Development Business (2019-2024)
11.19.5 Camtech Recent Developments
11.20 SynVivo
11.20.1 SynVivo Company Details
11.20.2 SynVivo Business Overview
11.20.3 SynVivo Custom Assay Development Introduction
11.20.4 SynVivo Revenue in Custom Assay Development Business (2019-2024)
11.20.5 SynVivo Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
2BScientific
PerkinElmer
Eurofins Discovery
Thermo Fisher Scientific
Creative Biolabs
PlexBio
Gyros Protein Technologies
Mission Bio
Sygnature Discovery
AssayGate
Charles River Laboratories
Promega Corporation
ProteoGenix
R&D Systems
Luminex
Eremid Genomic Services
INDIGO Biosciences
Cellomatics Biosciences
Camtech
SynVivo
Ìý
Ìý
*If Applicable.
